2 - Preparation and Performance
2 - Preparation and Performance
Objectives
1. Identify the components of PFTs
PFTs
o Four lung components include :
❖ The airways (large and small)
❖ Lung parenchyma (alveoli, interstitium)
❖ Pulmonary vasculature
❖ The bellows-pump mechanism
o PFTs can include: simple screening spirometry, Flow Volume Loop, Formal
lung volume measurement, Bronchoprovocation testing, Diffusing capacity for
carbon monoxide, Arterial blood gases, Measurement of maximal respiratory
pressures
Incentive spirometer
Peak flow meter
Indications of PFT
1. Symptoms and clinical signs
➢ Dyspnea with or without or wheezing
➢ Chest pain or orthopnea
➢ Chronic Cough with or without phlegm production
➢ Cyanosis, Decreased or unusual breath sounds
2. Abnormal chest x-ray (e.g. Hyperinflation)
3. Abnormal blood gases (hypoxemia, hypercapnia)
4. Abnormal laboratory findings (e.g. polycythemia)
5. Monitoring of known pulmonary diseases
6. 6. Diagnosis of lung disease
7. Assessing severity or progression of disease (e.g. asthma, COPD)
➢ Control of therapy, e.g. Bronchodilatator or steroids.
➢ Assessing reversibility (asthma versus COPD)
8. Preoperative assessment
9. Further Indications for spirometry:
➢ Periodic examinations in high-risk groups
➢ Course of FEV1 in smokers
➢ Risk stratification of patients for surgery
➢ Check-up
➢ Evaluating disability or impairment
➢ Extrapulmonary diseases with lung involvement
Indications of PFT continue ………….
Prognostic indications
o Assess severity of lung disease
o Disability assessment
Contraindications of PFT
➢ Mechanical properties
➢ Resistive elements
Infection control and safety during PFT
Infection control and safety during spirometry
1.Spirometers should be cleaned according to the manufacturer´s
recommendations
2.The mouthpiece, nose clips, tubing, and any parts of the instrument that come
into direct contact with a patient should be disposed, sterilized, or disinfected
between patients.
3.Any equipment surface showing visible condensation from exhaled air should
be discarded, disinfected, or sterilized before reuse.
4.Change of mouthpiece: the change of the mouthpiece should be visible to the
patient. Alternatively disposable bacteria filters should be used.
5.Bacterial filters should always be used in infectious pts (e.g. MRSA, HIV,
hepatitis B, TB), as well as in patients with immunodeficiency (e.g.
chemotherapy, post-transplantation, CF).
6.A mask should be worn by the technologist when testing subjects who have
active TB or other serious diseases that can be transmitted by coughing.
7.Proper hand washing & Gloves should be worn when handling potentially
contaminated equipment.
8.Practitioners should wear gloves when handling potentially contaminated
mouthpieces, valves, tubing, and equipment surfaces.
9.When performing procedures on patients with potentially infectious airborne
diseases, practitioners should wear a personal respirator or a close-fitting surgical
mask, especially if the testing induces coughing.
10.Practitioners should always wash their hands between testing patients and after
contact with testing equipment.
Preparation & Instructions given to patient before PFT
Patient Instructions Prior to Testing should be given to patient at time of appointment
➢ Should wait at least one month post MI, consider impact of problems that may
affect results (chest/abdominal pain, oral or facial pain, stress incontinence,
dementia, physical deformities or medical conditions)
➢ Physical and mental rest.
➢ Should not drink alcohol for four hours prior to test
➢ No coffee or tea or smoking at least one hour before test
➢ Do not eat a large meal two hours prior to test
➢ No vigorous exercise 30 minutes before test
➢ Do not wear tight form fitting clothes
➢ May need to remove loose dentures for test
➢ Bring a list of all medications – potentially withhold bronchodilators,
corticosteroids
➢ Withholding bronchodilators preparations (see next slide)
➢ Empty the bladder in females or those with history of urinary incontinence
immediately before the test .
Basics, Current Recommendations & interpretation of PFT
Guidelines for withholding medical preparations
Medications may be continued if the PFT aims to assess the patient condition on
treatment (controlled or not)
B2 agonists
Anticholinergic
Theophylline
Corticosteroids
Valid end-of-test
A. Smooth curvilinear rise of the volume-time tracing to a plateau
of at least 1-second duration;
B. If a test fails to exhibit an expiratory plateau, a forced expiratory
time (FET) of 15 seconds; or
C. When the patient cannot or should not continue forced
exhalation for valid medical reasons.
If both of these criteria are not met, continue testing until: Both of
the criteria are met with analysis of additional acceptable spirograms
or
A total of eight tests have been performed or
Save a minimum of three best maneuvers
Spirometry technique: positioning
Test position: The test position should be noted on the report
Seating Position
➢The standing position is not advised, because most reference equations refer to the seating
position.
➢Besides, in case of dizziness during the forced exhalation, seating helps to maintain the balance.
Upright position
➢It is important to instruct the patient to sit erect, because the lungs need abdominal space
to reach maximal volume.
➢Instruct the subject to loosen tight clothing that may interfere with maximal inspiration.
Handheld-spirometers
➢Keep an eye on the head position; patients tend to bow their head forward during expiration.
➢Look out!
• Flexion at forced manoeuvre
• Support arm recommended
➢Correct position of mouthpiece and nose clip
Spirometry technique: Recommendations for better results
➢Patient should be examined relaxed and free of stress. Minimum 15 min. rest before the test
➢The measurement should be done in the sitting position with correct position of head and body.
➢Make a record of the patient’s sex, age and height and sometimes race.
➢Parameters measured in standing position are not better than in sitting position but different; parameter
values in standing position are 2-7% increased
➢Measurement should only be monitored and not yet recorded until the patient is regular breathing! No
hurry!
➢Instructions about maintaining a good seal around the mouthpiece can help reduce leaks. The correct
sealing of the lips can be inspected only visually! In the course of the measurement several times
checking.
➢The maximum inhalation to TLC, which is IVC, should be performed not only to the maximum
inspiratory volume but also with maximal speed and effort.
➢For maximal inhalation the patient needs on average 2 to 4 seconds. If the inspiratory time is increased,
most flows of the following forced exhalation are diminished.
➢The patient should be assured, that repeating the test is required and does not reflect a problem of their
part.
➢Clinical interpretation always in the combination of parameters and graphical appearance of
flow/volume loop (v.v.imp).
➢Values can be compared with predicted normal values.
Basics, Current Recommendations & interpretation of PFT
Breathing manoeuvres
Forced spirometry with flow/volume-curve
➢From tidal breathing a slow and maximal exhalation has to be performed. After reaching the point of maximal
exhalation (no.1) the patient inspires fast and maximal (no.1, 2, 3) on instruction.
➢Immediately after reaching maximal inspiration (no.3) the patient should blast out suddenly with maximal effort; time of
exhalation 6 (4) seconds or there is no change in volume any more (no.3, 4, 5 right hand)
➢After every trial… pause of 30 - 40 seconds for recovery
• The maneuver may be performed in a forceful manner to generate (FVC) or in a more relaxed manner
to generate a slow vital capacity (SVC).
Spitometry technique: reporting
❑ When the slow or forced vital capacity is within the normal range:
❖ No significant restrictive disorder .
❖ No need to measure static lung volumes (residual volume and total lung
capacity).
❖ The maneuver may be performed in a forceful manner to generate a forced
vital capacity (FVC) or in a more relaxed manner to generate a slow vital
capacity (SVC).
❖ In normal persons, the inspiratory vital capacity, the expiratory SVC, and
expiratory FVC are essentially equal. However, in patients with
obstructive airways disease, the expiratory SVC is generally higher than
the FVC.
Useful Videos
https://www.youtube.com/watch?v=629HPu8C2Gs
https://www.youtube.com/watch?v=Zs8Fs5HaJHs
https://www.youtube.com/watch?v=Xeps-PD0r8g
https://www.youtube.com/watch?v=teqX9U2BzYc
https://www.youtube.com/watch?v=v6pW9FWz8RM
Assignment
Each group should discuss with each other and have a final
version of the instructions